VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 100 filers reported holding VERONA PHARMA PLC in Q3 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $118,000 | -35.9% | 18,035 | -18.0% | 0.01% | -40.0% |
| Q1 2021 | $184,000 | +119.0% | 22,000 | +83.3% | 0.01% | +42.9% |
| Q4 2020 | $84,000 | -68.9% | 12,000 | -72.3% | 0.01% | -73.1% |
| Q3 2020 | $270,000 | -47.2% | 43,300 | -60.3% | 0.03% | -45.8% |
| Q2 2020 | $511,000 | +75.0% | 109,100 | +53.8% | 0.05% | +37.1% |
| Q1 2020 | $292,000 | -37.3% | 70,950 | -12.5% | 0.04% | -14.6% |
| Q4 2019 | $466,000 | +235.3% | 81,100 | +167.5% | 0.04% | +192.9% |
| Q3 2019 | $139,000 | +12.1% | 30,315 | +24.7% | 0.01% | +16.7% |
| Q2 2019 | $124,000 | -23.0% | 24,315 | -2.0% | 0.01% | -29.4% |
| Q1 2019 | $161,000 | +26.8% | 24,800 | +75.5% | 0.02% | +6.2% |
| Q4 2018 | $127,000 | – | 14,130 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |